U.K. Labour Leader Jeremy Corbyn calls for use of compulsory licensing, public sector manufacturing and pricing controls on drugs using government funded inventions

Today, in his address to the U.K. Labour party conference, Labour Leader Jeremy Corbyn made the following statement on drug patents and prices. Yesterday I met Luis Walker, a wonderful nine-year-old boy. Luis is living with cystic fibrosis. Every day… Continue Reading

Joint Comments by KEI, UACT, Social Security Watch and Health Gap on the proposed NIH Exclusive License in CAR Therapy to Lyell Immunopharma

On September 19, 2019, Knowledge Ecology International (KEI), Union for Affordable Cancer Treatment (UACT), Social Security Works (SSW), Health GAP, and Brook Baker submitted comments regarding the “Prospective Grant of an Exclusive Patent License: Development and Commercialization of CD19/CD22 Chimeric… Continue Reading

Joint Comments Regarding NIH Proposed Exclusive License to Intima Biosciences for Cancer Therapy (and NIH Response)

(UPDATE: The NIH provided a response to our comments on September 26, 2019) On September 13, 2019, Knowledge Ecology International (KEI), Union for Affordable Cancer Treatment (UACT), Public Citizen (PC), Social Security Works (SSW), LWC Health, Ruth Lopert, Manon Ress,… Continue Reading

KEI Request Re: Failure to Disclose Federal Funding in UPenn Bennett et al Patents for Gene Therapy to Treat Blindness

On September 9, 2019, KEI submitted a second request to the NIH that it investigate an apparent failure to disclose federal funding in patents in adeno-associated viral (AAV) gene therapies assigned to the Trustees of the University of Pennsylvania (UPenn).… Continue Reading

KEI, UACT, UAEM, and SSW Appeal NIH Grant of Exclusive Licenses on CAR Cancer Therapy to Gilead/Kite

On September 12, 2019, Knowledge Ecology International (KEI), Union for Affordable Cancer Treatment (UACT), Universities Allied for Essential Medicines (UAEM), Social Security Works (SSW), and Clare Love filed an appeal with the National Institutes of Health (NIH). The signatories appealed… Continue Reading

KEI letter to Senator Coons regarding injunction provisions in STRONGER Patents Act

KEI-Sen-Coons-injunctions-strongpatentsact-11Sept2019 September 11, 2019 The Honorable Senator Christopher Coons 218 Russell Senate Office Building Washington, DC 20510 Dear Senator Coons: Knowledge Ecology International (KEI) is a public interest group based in Washington, DC. KEI focuses on policies relating to the… Continue Reading

FOIA: Records of USTR Lighthizer Bilateral Meetings at 2018 World Economic Forum in Davos

Through a Freedom of Information Act request, KEI has obtained records relating to US Trade Representative Ambassador Robert Lighthizer’s attendance at the 2018 World Economic Forum in Davos, Switzerland. While many of the records were related to scheduling and re-scheduling… Continue Reading